Copart, IncNasdaq: CPRT
Industrials · Diversified Support Services
$30.28
+2.57%
Vol: 10.4M
Research Digest
Friday, June 19, 2026
Copart shares fall 4% to near multi-year lows as Renaissance exits position; JPMorgan and Barclays cut price targets on fee pressure
Copart (CPRT) shares fell 4.0% on June 17, 2026 to approximately $29.52, extending a 36% decline over the past year. Renaissance Investment Management exited its position, citing deterioration in fundamental factors including rising auto-insurance costs that are dampening auction volumes. JPMorgan and Barclays trimmed price targets to $34 and $32 respectively, citing competitive fee rate pressure and a prior earnings miss. In Q3 FY2026, Copart reported consolidated revenue of $1.24 billion, up 2.1% year over year, with EPS of $0.43, beating consensus by $0.02. Despite the stock trading near a multi-year low, analysts maintain an average price target of $46.22, implying 36.8% upside, and a DCF analysis suggests the stock is undervalued by approximately 20%. Key risks include continued insurance market normalization and competitive pressure on auction take rates.
Previous Market Intelligence
13 daysJun 18No significant overnight updatesNeutral▶
No material news in the last 48 hours.
Jun 17No significant overnight updatesNeutral▶
No material news in the last 48 hours.
Jun 16No significant overnight updatesNeutral▶
No material news in the last 48 hours.
Jun 15No significant overnight updatesNeutral▶
No material news in the last 48 hours.
Jun 14No significant overnight updatesNeutral▶
No material news in the last 48 hours.
May 21Copart reports Q3 fiscal 2026 earnings May 21; analysts expect $0.41 EPS on $1.20B revenueNegative▶
Copart will release Q3 fiscal 2026 earnings after market close on Thursday, May 21, 2026, with a conference call at 5:30 PM ET. Wall Street consensus expects EPS of $0.41 on revenue of $1.20B, with the market projecting revenue decline of 2.1% YoY. Short interest is rising ahead of the report. The company missed Q2 estimates with $1.12B revenue (-3.6% YoY). JPMorgan and Barclays trimmed price targets to $34 and $32 citing fee pressure from insurance partners. Stock at $32.30 as of May 15.
May 20Copart heads into Q3 fiscal 2026 earnings on May 21 with short interest up 8% and price targets cut to $32-$34 amid fee-rate competitive pressure.Negative▶
Copart will report Q3 fiscal 2026 results after market close on May 21, with Wall Street expecting EPS of $0.41 on revenue of $1.20B, a 2.4% YoY EPS decline. Short interest rose 7.99% to ~32.79M shares (3.76% of float) as of April 30 ahead of the print. Analysts have trimmed targets, with JPMorgan to $34 and Barclays to $32, citing competitive pressure on fee rates following a Q2 miss where revenue fell 3.6% YoY to $1.12B and EPS dropped to $0.36 from $0.40. The setup creates elevated risk into the print given recent execution concerns. Average price target now sits at $42.67 with the stock around $32-$33.
May 19Copart short interest rose ~8% ahead of May 21 fiscal Q3 2026 earnings as analysts trim price targets on competitive fee pressure.Negative▶
As of disclosures around May 18, 2026, Copart's short interest climbed ~7.99% to roughly 32.8M shares (~3.76% of float) heading into its fiscal Q3 2026 earnings release on May 21, 2026. The setup is cautious: JPMorgan and Barclays trimmed targets to $34 and $32 citing spreading competitive pressure on fee rates after Q2 2026 missed (EPS $0.36 vs $0.40 prior, revenue down 3.6% YoY). This matters because earnings are the next binary catalyst, with consensus revenue around $1.20B. Bear case: continued fee compression from IAA/competitive auction platforms could pressure margins; shares are down ~45% YoY.
May 18Copart heads into May 21 Q3 FY2026 earnings with stock down 45% YoY at $32.30Mixed▶
Copart will report fiscal Q3 2026 results after the close on Thursday, May 21, followed by a 5:30 p.m. ET conference call. Shares traded around $32.30 as of May 15 with a market cap near $31.4B, reflecting a 45.5% decline over the past year amid ongoing insurance-volume headwinds. Street price targets range roughly $33-$52 as analysts weigh share-loss risk with insurance carriers. The UK unit also disclosed sustainability work with supply-chain partners to reduce Scope 3 emissions. The earnings print and any commentary on insurance-customer share will be the key near-term catalyst.
May 15Copart confirms Q3 FY2026 earnings release on May 21 as JPMorgan and Barclays cut price targets ahead of reportNegative▶
Copart announced it will release Q3 fiscal 2026 results after market close on Thursday, May 21, 2026, followed by a conference call. JPMorgan cut its price target to $34 from $45 and kept a Neutral rating, while Barclays lowered its target to $32 from $33 with an Underweight rating. Shares trade around $39.15, down 14% over the last 90 days and roughly 45.6% over the past year. Average analyst rating is Hold, with a consensus 12-month target near $44.4 implying ~31% upside. Investors will watch for commentary on insurance volumes and international segment growth on May 21.
May 14Copart sets Q3 fiscal 2026 earnings release for May 21 amid 45% one-year stock decline and analyst price target cuts.Negative▶
Copart announced it will release Q3 fiscal 2026 results after market close on May 21, 2026, with consensus EPS estimate of $0.41. The stock has declined approximately 16% over the past 3 months and 45.66% over the past year, currently trading near $33.94. Analyst sentiment is cautious: JPMorgan lowered its price target to $34 from $45 (Neutral), and Barclays cut to $32 from $33 (Underweight). The prior quarter (Feb 19) saw an EPS miss at $0.36 versus $0.39 consensus. CEO Jeffrey Liaw sold 26,213 shares on April 15 at $33.18. Average analyst rating is Hold with a 12-month target of $44.40.
May 13Copart heads into its May 21 earnings report under analyst pressure after Barclays initiated Underweight and Weiss Ratings downgraded the stock to Sell.Negative▶
Copart is scheduled to report fiscal Q3 2026 results on May 21, 2026, with consensus EPS of $0.41. The stock has been under sustained pressure, down ~16% over the past three months and ~45% over the past year. Analyst sentiment has soured: Barclays initiated coverage at Underweight with a $32 price target, JPMorgan trimmed its target to $34 (from $45) keeping a Neutral rating, and Weiss Ratings downgraded CPRT from Hold to Sell on May 1. Provident Investment Management cut its CPRT stake by 41.6% in its most recent 13F. Despite the bearish tone, the consensus average price target of $44.40 still implies ~30% upside from current levels, with consensus rating Hold across 5 analysts.
May 12Copart faces weak demand as JPMorgan and Barclays cut targets to $34/$32 and Weiss downgrades to sell ahead of May 21 earningsNegative▶
Copart faces a bearish narrative ahead of its May 21 fiscal Q3 2026 earnings (EPS estimate $0.41), with shares down 45% over the past year to $33.29. JPMorgan lowered its price target to $34 from $45 (Neutral), and Barclays cut to $32 from $33 (Underweight) on competitive pressure and weak demand for used vehicles. Weiss Ratings downgraded from Hold (C-) to Sell (D+) on May 1. CEO Jeffrey Liaw sold 26,213 shares on April 15 at $33.18 totaling ~$870K. Provident Investment Management cut its position 41.6% in Q4. Consensus rating Hold with $44.40 average target implying ~31% upside.
Sector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| CTASCINTAS | $170.87 | +0.73% | -0.3% | 31.5x | 0.93 | $68.4B |
| CPRTCOPART | $30.28 | +2.57% | -8.5% | 17.9x | 1.00 | $28.0B |
| LDOSLEIDOS | $107.02 | -1.52% | -13.9% | 8.1x | 0.52 | $13.5B |
| CATCATERPILLAR | $991.23 | +3.69% | +13.0% | 32.8x | 1.60 | $454.1B |
| GEGENERAL | $359.14 | +0.59% | +19.1% | 41.2x | 1.38 | $373.7B |
| GEVGE | $1,111.86 | +6.01% | +8.3% | 45.3x | 1.04 | $298.2B |
Key Fundamentals
RSI (14-Day)
52-Week Range
Moving Averages
Price below 200d MA — bearish structure.